Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cadonilimab Combined With Chemotherapy Followed by Concurrent Chemoradiotherapy in Locally Advanced Cervical Cancer
NCT07400536Phase 3Recruiting
- Start
- Apr 2026
- Primary completion
- Jul 2028
- Modality
- Bispecific Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of cadonilimab in Cervical Cancer (CC). Started Apr 2026; status: recruiting.
02
Drugs
cadonilimab
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT07400536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07400536.